TrendTrade2016 Tuesday, 01/31/17 05:58:17 AM Re: None Post # of 4 AMS is our next cancer treatment company with extreme growth on the balance sheet. This company has a near perfect business model and is a profitable company. They are in the radiation side to treating tumors. They do not manufacture this revolutionary equipment they invest in the companies that do and lease this equipment to surgical centers. With two of the most advanced technologies in this space we see AMS trading much higher going forward. The insiders are buying up the float preventing this company to be a short target and with a 3.7 m float it will move very fast.